Global biosimilar regulatory harmonization will be needed to reduce development costs and improve patient access, despite ...
Bayer’s consumer health business benefits from a narrow economic moat, largely because of its strong brand power. Consumers continue to pay a premium for Aspirin, Aleve, and other over-the-counter ...
20h
24/7 Wall St. on MSNGoldman Sachs Sees 2025 Dividend Growth and 4 High-Yield Passive Income Stocks Are Strong BuysFour Goldman Sachs stock picks make sense for growth and income investors charting a course for the rest of what could be a ...
The appeals court for the Federal Circuit upheld a lower court’s ruling, finding that Regeneron has not sufficiently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results